NASDAQ:CRSP

CRISPR Therapeutics Earnings Date, Estimates & History

$120.85
-0.17 (-0.14 %)
(As of 08/2/2021 10:27 AM ET)
Add
Compare
Today's Range
$119.97
$123.00
50-Day Range
$109.83
$161.89
52-Week Range
$76.71
$220.20
Volume16,329 shs
Average Volume1.77 million shs
Market Capitalization$9.16 billion
P/E Ratio23.65
Dividend YieldN/A
Beta2.26

CRISPR Therapeutics (NASDAQ:CRSP) Earnings Information

CRISPR Therapeutics last issued its quarterly earnings data on July 29th, 2021. The reported $9.44 EPS for the quarter, topping the consensus estimate of $3.52 by $5.92. CRISPR Therapeutics has generated ($5.29) earnings per share over the last year ($5.11 diluted earnings per share) and currently has a price-to-earnings ratio of 23.6. Earnings for CRISPR Therapeutics are expected to decrease in the coming year, from $0.66 to ($6.23) per share. CRISPR Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, October 27th, 2021 based off prior year's report dates.

CRISPR Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CRISPR Therapeutics (NASDAQ:CRSP) Earnings Estimates

2021 EPS Consensus Estimate: ($0.87)
2022 EPS Consensus Estimate: ($7.21)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20216($1.65)($1.37)($1.47)
Q2 20216($1.81)$10.43$2.24
Q3 20216($1.88)$7.39($0.11)
Q4 20215($1.70)($1.39)($1.53)
Q1 20222($1.82)($1.60)($1.71)
Q2 20222($1.95)($1.63)($1.79)
Q3 20222($2.07)($1.53)($1.80)
Q4 20222($2.26)($1.56)($1.91)

CRISPR Therapeutics (NASDAQ CRSP) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
10/27/2021
(Estimated)
        
7/29/20216/30/2021$3.52$9.44+$5.92$9.44
4/26/20213/31/2021($1.47)($1.51)($0.04)($1.51)$4.99 million$0.54 million
2/15/202112/31/2020($1.27)($1.50)($0.23)($1.50)$4.69 million$0.37 million
11/2/20209/30/2020($1.18)($1.32)($0.14)($1.32)$2.22 million$0.15 million
7/27/20206/30/2020($0.95)($1.30)($0.35)($1.30)$19.77 million$0.04 million
4/28/20203/31/2020($1.05)($1.15)($0.10)($1.15)$3.04 million$0.16 million
2/12/2020Q4 2019($0.68)$0.51+$1.19$0.51$39.08 million$77.00 million
10/28/2019Q3($0.9480)$2.40+$3.3480$2.40$6.32 million$211.93 million
7/29/2019Q2($0.17)($1.01)($0.84)($1.01)$47.57 million$0.32 million
4/29/2019Q1($0.90)($0.93)($0.03)($0.93)$1.50 million$0.30 million
2/25/2019Q4 2018($0.83)($0.92)($0.09)($0.92)$1.56 million$0.10 million
11/8/2018Q3($0.74)($1.07)($0.33)($1.07)$2.64 million$0.56 million
8/8/2018Q2($0.6310)($0.82)($0.1890)($0.82)$1.47 million$1.09 million
5/9/20183/31/2018($0.67)($0.62)+$0.05($0.62)$3.64 million$1.36 million
11/8/2017Q3($0.60)($0.62)($0.02)($0.62)$3.61 million$2.39 million
8/10/20176/30/2017($0.62)($0.56)+$0.06($0.56)$3.29 million$3.60 million
5/11/20173/31/2017($0.60)($0.54)+$0.06($0.54)$2.70 million
3/10/2017Q4 2016($0.38)($0.40)($0.02)($1.20)$2.34 million
11/22/2016Q3 2016($2.77)($2.77)($2.77)$1.55 million
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 8/2/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.